Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.09
+0.06 (1.19%)
Aug 18, 2026, 4:00 PM EDT - Market closed

Champions Oncology Cash Flow Statement

Millions USD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Income
-1.184.7-7.28-5.340.55
Depreciation & Amortization
1.381.641.871.621.63
Other Amortization
---0.63-
Loss (Gain) From Sale of Assets
0.110.290.44--0
Asset Writedown & Restructuring Costs
---0.81-
Stock-Based Compensation
1.240.651.120.860.91
Provision & Write-off of Bad Debts
0.03-0.270.480.20.29
Other Operating Activities
1.370.991.070.950.79
Change in Accounts Receivable
-2-1.44-1.991.31-2.82
Change in Accounts Payable
2.56-1.750.472.470.97
Change in Unearned Revenue
-6.623.35-0.681.714.82
Change in Other Net Operating Assets
-1.37-0.79-1.61-1.24-0.64
Operating Cash Flow
-4.477.39-6.143.976.5
Operating Cash Flow Growth
----38.86%-

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Capital Expenditures
-0.56-0.39-0.84-2.87-2.38
Sale of Property, Plant & Equipment
0.02----
Investing Cash Flow
-0.54-0.39-0.84-2.87-2.38

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Long-Term Debt Repaid
-0.14-0.15-0.15--
Net Debt Issued (Repaid)
-0.14-0.15-0.15--
Issuance of Common Stock
0.230.320.250.090.21
Repurchase of Common Stock
---0.63-0.07-
Financing Cash Flow
0.10.17-0.530.010.21

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Cash Flow
-4.917.17-7.51.114.32

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
-5.047-6.971.14.11
Free Cash Flow Growth
----73.26%-
Free Cash Flow Margin
-8.48%12.29%-13.90%2.04%8.38%
Free Cash Flow Per Share
-0.360.49-0.520.080.29
Levered Free Cash Flow
-4.295.42-4.22.883.86
Unlevered Free Cash Flow
-4.295.42-4.182.883.86

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Change in Working Capital
-7.42-0.62-3.824.242.34
SEC Filings: 10-K · 10-Q